In neonatal cholestasis, if the serum gamma glutamyl transpeptidase (GGT) is more than 600 IU/L, the most likely diagnosis is:
**Core Concept**
Gamma glutamyl transpeptidase (GGT) is an enzyme that plays a crucial role in the gamma-glutamyl cycle, which is essential for the synthesis and degradation of glutathione. Elevated GGT levels in neonatal cholestasis suggest a bile duct obstruction, as GGT is predominantly found in the bile duct epithelial cells.
**Why the Correct Answer is Right**
In neonatal cholestasis, a significantly elevated GGT level (>600 IU/L) points towards a bile duct obstruction. This is because GGT is released into the bloodstream when the bile ducts are damaged or obstructed. The most likely diagnosis in this scenario is biliary atresia, a condition characterized by the absence or obliteration of the bile ducts. Biliary atresia is a common cause of neonatal cholestasis and requires prompt surgical intervention. The high GGT levels in this condition are due to the release of the enzyme from the damaged bile duct epithelial cells into the bloodstream.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a bile duct obstruction, which is a key feature of the condition associated with significantly elevated GGT levels.
**Option B:** This option is incorrect because it does not mention a bile duct obstruction, and therefore does not explain the high GGT levels.
**Option C:** This option is incorrect because it refers to a condition that is not typically associated with significantly elevated GGT levels in neonatal cholestasis.
**Clinical Pearl / High-Yield Fact**
In neonatal cholestasis, a high GGT level (>600 IU/L) is a red flag for biliary atresia, and prompt surgical evaluation is essential to establish the diagnosis and initiate treatment.
**Correct Answer:** C. Biliary atresia.